How can oncology practices protect profitability amid reimbursement reform? The most successful oncology practices are strengthening financial performance by modernizing their […]
What is the future of oncology revenue cycle management? The future of oncology revenue cycle management (RCM) is autonomous, data-driven, and […]
What Is Oncology Revenue Cycle Management? Oncology revenue cycle management (RCM) is the process of managing every financial aspect of cancer […]
Prior Authorization Shouldn’t Delay Cancer Care In oncology, every day matters. Whether initiating chemotherapy, scheduling advanced imaging, administering immunotherapy, or obtaining […]
The Future of Oncology Won’t Be Won by Size Alone For years, the oncology industry’s competitive landscape has been defined by […]
Why Revenue Cycle Mastery Has Become a Strategic Imperative for Oncology Practices Cancer care has never been more advanced, or more […]
Why Payer Mix Isn’t the Whole Story Many oncology practices evaluate financial performance based on payer mix – Medicare, commercial, Medicaid, […]
The Growth Challenge Facing Oncology Infusion Centers Community oncology practices and infusion centers are experiencing steady growth driven by: An aging […]
The Hidden Cost of Fragmented Oncology Revenue Cycle Management Oncology revenue cycle management (RCM) is uniquely complex. Between chemotherapy drug billing, […]
In oncology, prior authorization is a critical step in ensuring patients receive timely, life-saving care. Given the high cost and complexity of treatments such as […]